Small-molecule-based targeted therapy in liver cancer
Y Ming, Y Gong, X Fu, X Ouyang, Y Peng, W Pu - Molecular Therapy, 2024 - cell.com
Liver cancer is one of the most prevalent malignant tumors worldwide. According to the
Barcelona Clinic Liver Cancer staging criteria, clinical guidelines provide tutorials to clinical …
Barcelona Clinic Liver Cancer staging criteria, clinical guidelines provide tutorials to clinical …
Heterocycles‐Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years
Cancer is one of the primary causes of mortality worldwide. Despite nowadays are
numerous therapeutic treatments to fight tumor progression, it is still challenging to …
numerous therapeutic treatments to fight tumor progression, it is still challenging to …
Discovery of a novel CDK4/6 and HDAC dual-targeting agent for the treatment of hepatocellular carcinoma
Z Niu, Z Shi, G Wu, Y Liu, W Xie, F Liu, T Fan, K Shu… - Bioorganic …, 2024 - Elsevier
The down-regulation of p21 after long-term CDK4/6 inhibition represents a key mechanism
causing resistance to CDK4/6 inhibitors in some tumor cells, while the HDAC inhibitor could …
causing resistance to CDK4/6 inhibitors in some tumor cells, while the HDAC inhibitor could …